Terms: = Lung cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Prognosis
32 results:
1. Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate.
Cui Y; Lin J; Sun D; Zhang H; Diao T; Fu Q
J Cancer Res Clin Oncol; 2024 Jan; 150(2):45. PubMed ID: 38281261
[TBL] [Abstract] [Full Text] [Related]
2. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
[TBL] [Abstract] [Full Text] [Related]
3. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
[TBL] [Abstract] [Full Text] [Related]
4. Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer-associated fibroblasts and immune and metabolism microenvironment.
Wei S; Bao M; Zhu Y; Zhang W; Jiang L
Environ Toxicol; 2023 Aug; 38(8):1951-1967. PubMed ID: 37186041
[TBL] [Abstract] [Full Text] [Related]
5. Identification of GPD1L as a Potential prognosis Biomarker and Associated with Immune Infiltrates in lung Adenocarcinoma.
Fan Z; Wu S; Sang H; Li Q; Cheng S; Zhu H
Mediators Inflamm; 2023; 2023():9162249. PubMed ID: 37035759
[TBL] [Abstract] [Full Text] [Related]
6. The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma.
Tong S; Jiang N; Wan JH; Chen CR; Wang SH; Wu CY; Guo Q; Xiao XY; Huang H; Zhou T
BMC Cancer; 2023 Mar; 23(1):275. PubMed ID: 36973678
[TBL] [Abstract] [Full Text] [Related]
7. cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.
Cheng X; Liu Y; Wang J; Chen Y; Robertson AG; Zhang X; Jones SJM; Taubert S
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35368077
[TBL] [Abstract] [Full Text] [Related]
8. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
[TBL] [Abstract] [Full Text] [Related]
9. Does Adding Femoral Lengthening at the Time of Rotation Hip Transposition After Periacetabular Tumor Resection Allow for Restoration of Limb Length and Function? Interim Results of a Modified Hip Transposition Procedure.
Xu H; Li Y; Zhang Q; Hao L; Yu F; Niu X
Clin Orthop Relat Res; 2021 Jul; 479(7):1521-1530. PubMed ID: 33534263
[TBL] [Abstract] [Full Text] [Related]
10. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract] [Full Text] [Related]
11. Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC).
Guo D; Yang L; Yang J; Shi K
Medicine (Baltimore); 2020 Jun; 99(26):e20431. PubMed ID: 32590728
[TBL] [Abstract] [Full Text] [Related]
12. Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data.
Wang Y; Wang Y; Wang Y; Zhang Y
Sci Rep; 2020 May; 10(1):8575. PubMed ID: 32444802
[TBL] [Abstract] [Full Text] [Related]
13. Targeting claudin-4 enhances chemosensitivity in breast cancer.
Luo Y; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Goto K; Nishiguchi Y; Mori T; Kawahara I; Kondoh M; Kuniyasu H
Cancer Sci; 2020 May; 111(5):1840-1850. PubMed ID: 32086991
[TBL] [Abstract] [Full Text] [Related]
14. Mesothelioma of the tunica vaginalis testis.
Butnor KJ; Pavlisko EN; Sporn TA; Roggli VL
Hum Pathol; 2019 Oct; 92():48-58. PubMed ID: 31376434
[TBL] [Abstract] [Full Text] [Related]
15. Fabrication, optimization, and
Mathur P; Sharma S; Rawal S; Patel B; Patel MM
J Liposome Res; 2020 Jun; 30(2):182-196. PubMed ID: 31060404
[TBL] [Abstract] [Full Text] [Related]
16. High-frequency power of heart rate variability can predict the outcome of thoracic surgical patients with acute respiratory distress syndrome on admission to the intensive care unit: a prospective, single-centric, case-controlled study.
Chen IC; Kor CT; Lin CH; Kuo J; Tsai JZ; Ko WJ; Kuo CD
BMC Anesthesiol; 2018 Apr; 18(1):34. PubMed ID: 29609546
[TBL] [Abstract] [Full Text] [Related]
17. Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.
Kaspi E; Frankel D; Guinde J; Perrin S; Laroumagne S; Robaglia-Schlupp A; Ostacolo K; Harhouri K; Tazi-Mezalek R; Micallef J; Dutau H; Tomasini P; De Sandre-Giovannoli A; Lévy N; Cau P; Astoul P; Roll P
PLoS One; 2017; 12(8):e0183136. PubMed ID: 28806747
[TBL] [Abstract] [Full Text] [Related]
18. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
[TBL] [Abstract] [Full Text] [Related]
19. 36 cases adenoid cystic carcinoma of the breast in China: Comparison with matched grade one invasive ductal carcinoma-not otherwise specified.
Wang S; Li W; Wang F; Niu Y; Hao C; Wang X; He L; Tong Z
Pathol Res Pract; 2017 Apr; 213(4):310-315. PubMed ID: 28222936
[TBL] [Abstract] [Full Text] [Related]
20. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract] [Full Text] [Related]
[Next]
